ncRNA basic information
ncRNA ID:
MI0003139
ncRNA Database:
miRBase
ncRNA Name:
miR-181d
ncRNA Type:
miRNA
ncRNA Expression:
up-regulated
ncRNA Method:
RT-PCR
ncRNA Target Gene:
NA
ncRNA Pathway:
NA
Evidence (ncRNA-drug):
predicted
drug basic information
Drug ID:
DB00515 (APRD00359)
Drug Name:
Cisplatin
Drug Method:
Head and neck squamous cell carcinoma cell lines UMSCC-1 and SQ20B were treated with docetaxel at increasing concentrations to develop resistant cell lines. Parental and resistant cells were treated with cisplatin, 5-fluorouracil, paclitaxel, methotrexate, and doxorubicin to confirm cross-resistance. The miRNA pattern of resistant cells was then compared with their parental cells.
Drug Response:
resistant
Cancer basic information
Cancer:
head and neck squamous cell carcinoma
Tissue/Cell:
cell line (UMSCC-1 and SQ20B)
Other information
Title:
MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance.
Journal:
Head Neck
Published:
2011
PubMed ID:
21560177